Trans fatty acids and cardiovascular health: Translation of the evidence base

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 6, 2008, Pages 448-456

  Booker, C S ^a   Mann, J I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Coronary heart disease; Evidence based nutrition; Lipoproteins; SIGN guidelines; Trans fatty acids; WCRF framework

Indexed keywords

EDIBLE OIL; TRANS FATTY ACID;

ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; HUMAN; REVIEW; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; DIETARY FATS, UNSATURATED; EVIDENCE-BASED MEDICINE; HUMANS; RISK FACTORS; TRANS FATTY ACIDS;

ANIMALIA; BOVIDAE;

EID: 46049116261     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.02.005     Document Type: Review

References (63)

1. Evidence-based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 268 (1992) 2420-2425
2. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer's handbook (March, 2004). http://www.sign.ac.uk/guidelines/fulltext/50/index.html (last accessed 5th August 2007)
3. Vandenbroucke J.P. When are observational studies as credible as randomised trials?. Lancet 363 9422 (2004) 1728-1731 10.1016/S0140-6736(04)16261-2
4. Margetts B., Warm D., Yngve A., and Sjöström M. Developing an evidence-based approach to public health nutrition: translating evidence into policy. Public Health Nutr 4 6A (2001) 1393-1397
5. Katan M., and de Roos N. Toward evidence-based health claims for foods. Science 299 (2003) 206-207
6. Myers E. Systems for evaluating nutrition research for nutrition care guidelines: do they apply to population dietary guidelines?. J Am Diet Assoc 103 (2003) S34-S41 10.1016/j.jada.2003.09.035
7. World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. World Cancer Research Fund Expert Report. 1997. Available from: http://www.wcrf.org/ (last accessed 5th August 2007).
8. World Health Organization. WHO Technical Report Series 916. Diet, nutrition, and the prevention of chronic disease: report of a joint FAO/WHO expert consultation. Geneva, 2003.
9. Mann J. Translation of evidence into dietary recommendations. In: Vorster H.H., Blaauw R., Dhansay M.A., Kuzwayo P.M.N., Moeng L., and Wentzel-Viljoen E. (Eds). Proceedings of the 18th International Congress of Nutrition (2005 September 19-23), Nutrition Safari for Innovative Solutions, Durban, South Africa. 3-8055-8015-0
10. Health Canada. Health Canada Scientific Summary on US Health Claim. Dietary fat, saturated fat, cholesterol, trans fatty acids and coronary heart disease. Bureau of Nutritional Sciences, Health Canada; 2000 (Executive summary available as Appendix C at: http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/health_claims-allegations_sante_e.html#25; last accessed 5th August 2007).
11. Thomas L.H., and Scott R.G. Ischaemic heart disease and the proportions of hydrogenated fat and ruminant-animal fat in adipose tissue at post-mortem examination: a case-control study. J Epidemiol Community Health 35 (1981) 251-255
12. Thomas L.H., Winter J.A., and Scott R.G. Concentration of 18:1 and 16:1 transunsaturated fatty acids in the adipose body tissue of decedents dying of ischaemic heart disease compared with controls: analysis by gas liquid chromatography. J Epidemiol Community Health 37 (1983) 16-21
13. Thomas L.H., Winter J.A., and Scott R.G. Concentration of transunsaturated fatty acids in the adipose body tissue of decedents dying of ischaemic heart disease compared with controls. J Epidemiol Community Health 37 (1983) 22-24
14. Roberts T.L., Wood D.A., Riemersma R.A., Gallagher P.J., and Lampe F.C. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 345 (1995) 278-282 10.1016/S0140-6736(95)90274-0
15. Clarke R., Frost C., Collins R., Appleby P., and Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 314 (1997) 112-117
16. Mensink R.P., Zock P.L., Kester A.D., and Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77 (2003) 1146-1155
17. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., and Willett W.C. Trans fatty acids and cardiovascular disease. N Engl J Med 354 (2006) 1601-1613
18. Ascherio A., Katan M., Zock P., Stampfer M., and Willett W. Trans fatty acids and coronary heart disease. N Engl J Med 340 (1999) 1994-1998
19. Müller H., Kirkhus B., and Pedersen J.I. Serum cholesterol predictive equations with special emphasis on trans and saturated fatty acids. an analysis from designed controlled studies. Lipids 36 (2001) 783-791
20. Oh K., Hu F., Manson J., Stampfer M., and Willett W. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol 161 (2005) 672-679
21. Hu F.B., Stampfer M.J., Rimm E., Ascherio A., Rosner B.A., Spiegelman D., et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149 (1999) 531-540
22. Hu F.B., Stampfer M.J., Manson J.E., Grodstein F., Colditz G.A., Speizer F.E., et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 343 (2000) 530-537
23. Willett W.C., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Rosner B.A., et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341 8845 (1993) 581-585 10.1016/0140-6736(93)90350-P
24. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337 (1997) 1491-1499
25. Ascherio A., Rimm E., Giovannucci E., Spiegelman D., Stampfer M., and Willett W. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313 (1996) 84-90
26. Pietinen P., Ascherio A., Korhonen P., Hartman A.M., Willett W.C., Albanes D., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145 10 (1997) 876-887
27. Oomen C., Ocke M., Feskens E., van Erp-Baart M., Kok F., and Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357 (2001) 746-751 10.1016/S0140-6736(00)04166-0
28. Hulshof K.F., van Erp-Baart M.A., Anttolainen M., Becker W., Church S.M., Couet C., et al. Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 53 (1999) 143-157
29. Lemaitre R.N., King I.B., Mozaffarian D., Sotoodehnia N., Rea T.D., Kuller L.H., et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114 3 (2006) 209-215
30. Sun Q., Ma J., Campos H., Hankinson S., Manson J., Stampfer M., et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115 (2007) 1858-1865
31. Clifton P., Keogh J., and Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 134 (2004) 874-879 Erratum published in
32. Clifton P., Keogh J., and Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 134 (2004) 1848
33. Lopes C., Aro A., Azevedo A., Ramos E., and Barros H. Intake and adipose tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J Am Diet Assoc 107 2 (2007) 276-286
34. Aro A., Kardinaal A.F., Salminen I., Kark J.D., Riemersma R.A., Delgado-Rodriguez M., et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet 345 8945 (1995) 273-278 10.1016/S0140-6736(95)90273-2
35. Pedersen J.I., Ringstad J., Almendingen K., Haugen T.S., Stensvold I., and Thelle D.S. Adipose tissue fatty acids and risk of myocardial infarction - a case-control study. Eur J Clin Nutr 54 (2000) 618-625
36. Baylin A., Kabagambe E., Ascherio A., Spiegelman D., and Campos H. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 133 (2003) 1186-1191
37. Harris W.S., Reid K.J., Sands S.A., and Spertus J.A. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 99 2 (2007) 154-158
38. Lemaitre R.N., King I.B., Raghunathan T.E., Pearce R.M., Weinmann S., Knopp R.H., et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105 (2002) 697-701
39. Ascherio A., Hennekens C.H., Buring J.E., Master C., Stampfer M.J., and Willett W.C. Trans-fatty acids intake and risk of myocardial infarction. Circulation 89 (1994) 94-101
40. Turpeinen A.M., Mutanen M., Aro A., Salminen I., Basu S., Palmquist D.L., et al. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76 (2002) 504-510
41. Kuhnt K., Kraft J., Moeckel P., and Jahreis G. Trans-11-18:1 is effectively Delta9-desaturated compared with trans-12-18:1 in humans. Br J Nutr 95 (2006) 752-761
42. Emken E.A., Abraham S., and Lin C.Y. Metabolism of cis-12-octadecenoic acid and trans-9,trans-12-octadecadienoic acid and their influence on lipogenic enzyme activities in mouse liver. Biochim Biophys Acta 919 (1987) 111-121
43. Rosenthal M.D., and Whitehurst M.C. Selective effects of isomeric cis and trans fatty acids on fatty acyl delta 9 and delta 6 desaturation by human skin fibroblasts. Biochim Biophys Acta 753 (1983) 450-459
44. Chern J.C., and Kinsella J.E. The effects of unsaturated fatty acids on the synthesis of arachidonic acid in rat kidney cells. Biochim Biophys Acta 750 (1983) 465-471
45. Kinsella J.E., Bruckner G., Mai J., and Shimp J. Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadecadienoate on lipid composition, essential fatty acid, and prostaglandins: an overview. Am J Clin Nutr 34 (1981) 2307-2318
46. King I.B., Lemaitre R.N., and Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 83 (2006) 227-236
47. Mensink R.P., and Hornstra G. The proportion of trans monounsaturated fatty acids in serum triacylglycerols or platelet phospholipids as an objective indicator of their short-term intake in healthy men. Br J Nutr 73 (1995) 605-612
48. Skeaff C.M., and Gowans S. Home use of margarine is an important determinant of plasma trans fatty acid status: a biomarker study. Br J Nutr 96 (2006) 377-383
49. Boue C., Combe N., Billeaud C., Mignerot C., Entressangles B., Thery G., et al. Trans fatty acids in adipose tissue of French women in relation to their dietary sources. Lipids 35 (2000) 561-566
50. Chen Z.Y., Ratnayake W.M., Fortier L., Ross R., and Cunnane S.C. Similar distribution of trans fatty acid isomers in partially hydrogenated vegetable oils and adipose tissue of Canadians. Can J Physiol Pharmacol 73 (1995) 718-723
51. Tholstrup T., Raff M., Basu S., Nonboe P., Sejrsen K., and Straarup E.M. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 83 (2006) 237-243
52. Mozaffarian D., Pischon T., Hankinson S.E., Rifai N., Joshipura K., Willett W.C., et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79 (2004) 606-612
53. Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135 (2005) 562-566
54. Kummerow F.A., Zhou Q., Mahfouz M.M., Smiricky M.R., Grieshop C.M., and Schaeffer D.J. Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 74 (2004) 2707-2723 10.1016/j.lfs.2003.10.013
55. Niu S.L., Mitchell D.C., and Litman B.J. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 44 (2005) 4458-4465
56. Stachowska E., Dolegowska B., Chlubek D., Wesolowska T., Ciechanowski K., Gutowski P., et al. Dietary trans fatty acids and composition of human atheromatous plaques. Eur J Nutr 43 (2004) 313-318
57. Matthan N.R., Welty F.K., Barrett P.H., Harausz C., Dolnikowski G.G., Parks J.S., et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 24 (2004) 1092-1097
58. van Tol A., Zock P.L., van Gent T., Scheek L.M., and Katan M.B. Dietary trans fatty acids increase serum cholesterylester transfer protein activity in man. Atherosclerosis 115 (1995) 129-134 10.1016/0021-9150(94)05509-H
59. Riserus U. Trans fatty acids and insulin resistance. Atheroscler Suppl 7 (2006) 37-39 10.1016/j.atherosclerosissup.2006.04.008
60. Christiansen E., Schnider S., Palmvig B., Tauber-Lassen E., and Pedersen O. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 20 (1997) 881-887
61. Louheranta A.M., Turpeinen A.K., Vidgren H.M., Schwab U.S., and Uusitupa M.I. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 48 (1999) 870-875 10.1016/S0026-0495(99)90221-4
62. Lichtenstein A.H., Erkkila A.T., Lamarche B., Schwab U.S., Jalbert S.M., and Ausman L.M. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 171 (2003) 97-107 10.1016/j.atherosclerosis.2003.07.005
63. Odegaard A.O., and Pereria M.A. Trans fatty acids, insulin resistance, and type 2 diabetes. Nutr Rev 64 (2006) 364-372